Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive SummaryAlan J. Garber, Guillermo E. Umpierrez, Jeffrey I. Mechanick et al.|Endocrine Practice|2020Cited by 603
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 UpdateLawrence Blonde, Sandra Weber, Guillermo E. Umpierrez et al.|Endocrine Practice|2022Cited by 465
Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trialSusan L. Samson, Mandeep Bajaj|Diabetologia|2011Cited by 107
<i>SPTSSA</i> variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegiaSiddharth Srivastava, Tiphanie P. Vogel, Hagar Mor Shaked et al.|Brain|2023Cited by 34
A resource of lipidomics and metabolomics data from individuals with undiagnosed diseasesJennifer Kyle, Joan M. Stoler, Kelly G. Stratton et al.|Scientific Data|2021Cited by 18